Gujarat Themis Biosyn Board Approves ₹335 Crore Preferential Share Issue

Board approved preferential issue of up to 82,10,786 shares at Rs 408 each, aggregating up to Rs 335 Cr, subject to shareholder and exchange approvals. Novel second equity raise after the recent QIP, with the promoter group subscribing Rs 250 Cr and four non-promoter investors subscribing the balance. Adds potential dilution and funding flexibility; post-issue ownership, issue completion and use of proceeds remain unresolved pending approvals.